NIFTY 500 › Financial Services
Overview Technical Risk & rank Results Accounts Filings Guidance & governance
Filings
41 filings of CREDITACC since January 2025; the newest 40 below.
board outcome 16, presentation 9, results 8, transcript 8
| Filed | Type | Subject | |
|---|---|---|---|
| 26 Oct 2026 | transcript Dividend / buy-back, Guidance, Legal, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Transcript of the Conference Call for Q2 FY27 ResultsAI summaryCreditAccess Grameen filed the transcript of its Q2 FY27 results conference call held on October 22, 2026. Management reported record quarterly PAT of INR 502 Crore and H1 FY27 PAT of INR 995 Crore (against INR 778 Crore in H1 FY26); H1 ROA 5.9% and ROE 23.8%; AUM INR 30,946 Crore, up 19.5% YoY. Management raised FY27 guidance: ROA 5.2% to 5.8% (from 4% to 4.8%), ROE 21% to 24% (from 16% to 20%), NIM 14.4% to 14.7% (from 12.8% to 13.2%); AUM growth guidance of 20% to 25% retained; credit cost guidance of 3% to 4% maintained. Management said lending rates would be cut by 50 bps from October, and flagged drought-related repayment requests in parts of Maharashtra. Management said a USD 175 million ECB was signed in October 2026 and INR 940 Crore of domestic NCDs were mobilised in FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Oct 2026 | presentation Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its investor presentation for the quarter and half year ended September 30, 2026 (Q2 & H1 FY27). Q2 FY27: AUM INR 30,946 Cr (up 19.5% YoY), disbursements INR 6,355 Cr, NII INR 1,278 Cr, PPOP INR 970 Cr, PAT INR 502 Cr (up 298.7% YoY); GNPA 1.79%, NNPA 0.59%, CRAR 26.9%. H1 FY27: PAT INR 995 Cr (up 435.0% YoY), PPOP INR 1,843 Cr, write-offs INR 614 Cr. Management revised FY27 guidance citing superior H1 performance: AUM growth 20.0-25.0%, NIM 14.4-14.7%, C/I ratio 29.0-30.0%, credit cost 3.0-4.0%, ROA 5.2-5.8%, ROE 21.0-24.0%. Management said asset quality is back to pre-crisis levels, with collection efficiency at about 98% in Q2, and that pricing benefit of about 50 bps was given to customers from October 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Oct 2026 | board outcome Management change, Results | CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on October 22, 2026, which ran from 2:00 PM to 5:15 PM IST. The board approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with limited review reports attached. The board approved appointing Sharp & Tannan, Chartered Accountants (FRN: 003792S), as one of the Joint Statutory Auditors for a 3-year term from FY 2027-28, subject to shareholder approval, replacing Walker Chandiok & Co LLP, whose tenure ends at the AGM in 2027. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2026 | results Legal, Results | The Exchange had sought clarification from CREDITACCESS GRAMEEN LIMITED for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the CAI summaryThe company filed a clarification letter dated August 3, 2026 responding to an NSE query on its June 30, 2026 financial results, which showed identical standalone and consolidated figures. The company said its wholly owned subsidiary, CreditAccess India Foundation, is a Section 8 entity that undertakes CSR activities only and generates no revenue. The subsidiary's expenses are funded entirely by the company and recognised as CSR expenditure in the standalone financial statements, so consolidation adds no revenue or expense impact. Consequently, revenue figures in the standalone and consolidated statements remain the same. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 31 Jul 2026 | results | The Exchange has sought clarification from CREDITACCESS GRAMEEN LIMITED for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the C | |
| 29 Jul 2026 | transcript Dividend / buy-back, Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about TranscriptAI summaryCreditAccess Grameen filed the transcript of its Q1 FY27 results conference call, held on July 24, 2026. Management said AUM grew 16.4% YoY and 2.5% QoQ to INR 30,319 Crore, and PAT grew 720% YoY to INR 493 Crore, with ROA of 5.9% and ROE of 24.4% for the quarter. Management said credit cost was INR 212 Crore (0.72% non-annualised), Gross NPA was 2.18% and net NPA was 0.76%. Management said it is retaining its medium-term guidance of INR 50,000 Crore AUM by calendar 2028 and will review guidance after one more quarter. Management said it has seen no discernible impact so far from the West Asia crisis or El Nino. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jul 2026 | presentation Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its Q1 FY27 (quarter ended June 30, 2026) investor presentation under Regulations 30 and 46 of the SEBI Listing Obligations rules. Q1 FY27 AUM was INR 30,319 Cr (up 16.4% YoY, 2.5% QoQ), disbursements INR 6,107 Cr, NII INR 1,164 Cr, PPOP INR 873 Cr and PAT INR 493 Cr (up 719.7% YoY). GNPA was 2.18%, NNPA 0.76%, PAR 90+ 1.46%, CRAR 24.9% (Tier 1 24.2%), and ROA 5.9% / 4.0% and ROE 24.4% / 16.0% (reported / TTM basis). Credit cost was 0.72% (non-annualised) in Q1 FY27, against INR 525.7 Cr in Q2 FY26 and INR 212.5 Cr in Q1 FY27. Management said its asset quality is normalising, with lower PAR accretion and a PAR 1-90 ratio of 74 bps, back to pre-crisis levels. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jul 2026 | board outcome Capex, Dividend / buy-back, Results | CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on July 24, 2026, which ran from 1:30 PM to 5:45 PM (IST). The board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with limited review reports. The board approved raising up to ₹2,000 crore through a public issue of non-convertible debentures in the domestic market, in multiple tranches. The board also approved private placement of non-convertible debentures in the domestic market up to an aggregate ₹1,000 crore, in one or more tranches or series. Issue size, tenure, coupon and redemption terms are shown as "to be determined" in the filing. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 May 2026 | transcript Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about TranscriptAI summaryTranscript of CreditAccess Grameen's Q4 FY26 earnings conference call held May 08, 2026, filed under Regulation 30 and 46. Management said Q4 FY26 AUM grew 14.0% YoY and 11.4% QoQ, Q4 disbursements were INR 8,313 Crore, and PAT was INR 340 Crore (FY26 PAT INR 778 Crore; FY26 credit cost 6.74% vs guidance of 5.5%-6.0%). Management guided FY27 AUM growth of 20.0%-25.0%, NIM of 12.8%-13.2%, cost-to-income of 33.0%-35.0%, credit cost of 3.0%-4.0%, ROA of 4.0%-4.8% and ROE of 16.0%-20.0%. Management said the new ECL model added INR 39 Crore of provisioning in Q4 for the West Asia crisis, and that April and early May PAR accretion was stable. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 08 May 2026 | presentation Dividend / buy-back, Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its investor presentation for the quarter and financial year ended March 31, 2026. Q4 FY26: AUM INR 29,590 Cr (+14.0% YoY), PAT INR 340 Cr (+619.4% YoY), NIM 14.2%, GNPA 3.17%, NNPA 1.12%, CRAR 24.4%. FY26: disbursements INR 24,859 Cr (+24.1% YoY), PAT INR 778 Cr (+46.3% YoY), ROA 2.7%, ROE 10.7%, write-offs INR 1,968 Cr. Management states that FY26 growth guidance was achieved despite 7.6% write-offs in FY26. Management says monthly PAR 15+ accretion has trended lower, with PAR 1-90 at 70 bps, back to pre-crisis levels. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 08 May 2026 | board outcome Results | CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2026.AI summaryCreditAccess Grameen Limited's board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, at a meeting held on May 08, 2026 (2:00 PM to 5:30 PM IST). The filing encloses the audited results with the auditor's report, which is dated May 08, 2026 and issued by Walker Chandiok & Co LLP and Varma & Varma. The auditors gave an unmodified opinion on the standalone results, with a declaration to that effect under Regulation 33(3)(d) and 52(3)(a) of the Listing Regulations. The financial figures themselves (revenue, profit, dividend) are not stated in the pages provided. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 27 Jan 2026 | transcript Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about TranscriptAI summaryCreditAccess Grameen filed the transcript of its Q3 FY26 results conference call, held on January 20, 2026, under Regulation 30 and Regulation 46 of the SEBI LODR Regulations. Management (MD and CEO Ganesh Narayanan) said X bucket collection efficiency was 99.71% in December 2025, and monthly PAR 15+ accretion fell to 18 bps in December 2025 from 47 bps in September 2025. Management reported Q3 FY26 disbursements of INR 5,767 Crore, up 13.4% YoY, and portfolio of INR 26,566 Crore; net interest income of INR 977 Crore; and PAT of INR 252 Crore. Management guided FY27 credit cost of 4% to 4.5%, based on a new PAR 15+ accretion of 30-35 bps per month, and said it will revisit this guidance around May after monitoring PAR trends. Management said microfinance growth is expected to stay in the early teens, with retail finance contributing the rest of growth, and that loan approval rates for new borrowers have fallen to 55% to 60%. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 20 Jan 2026 | board outcome Management change, Results | CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended December 31, 2025.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on January 20, 2026 (meeting 2:00 PM to 5:45 PM IST). The board approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with a limited review report from the auditors (Walker Chandiok & Co LLP and Varma & Varma). The board approved the grant of 9,12,500 stock options to eligible employees under the CAGL Employees Stock Option Plan – 2011, at an exercise price of ₹1344.97 per share. Options vest 25% each year over four years from the date of grant and can be exercised within 36 months of vesting. Diluted earnings per share as on December 31, 2025 were ₹15.68. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 20 Jan 2026 | presentation Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its Q3 and 9M FY26 investor presentation (quarter ended December 31, 2025) under Regulations 30 and 46 of the SEBI LODR. Q3 FY26 gross loan portfolio (GLP) was INR 26,566 Cr, up 7.1% YoY and 2.6% QoQ; disbursements were INR 5,767 Cr, up 13.4% YoY. Q3 FY26 PAT was INR 252 Cr (adjusted PAT INR 266 Cr, excluding a one-time INR 18 Cr impact from new labour codes); GNPA was 4.04% and NNPA 1.36%. Credit cost fell from INR 572 Cr in Q1 to INR 526 Cr in Q2 and INR 343 Cr in Q3 FY26, per the presentation. Management said new PAR 15+ accretion has pulled back since November 2025, with monthly accretion at 0.18% in December 2025 versus 0.47% in September 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 20 Jan 2026 | board outcome Management change, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on January 20, 2026.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on January 20, 2026 (meeting ran from 2:00 PM to 5:45 PM IST). The board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with a limited review report from the auditors. The board approved the grant of 9,12,500 stock options to eligible employees under the CAGL Employees Stock Option Plan – 2011, with an exercise price of ₹1344.97 per share. Options vest 25% each year over four years from the date of grant and may be exercised within 36 months of vesting. Diluted earnings per share as on December 31, 2025 were ₹15.68. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 19 Jan 2026 | results Results | The Exchange had sought clarification from CREDITACCESS GRAMEEN LIMITED for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the CAI summaryCreditAccess Grameen responded to an NSE query dated January 12, 2026 on its financial results for September 30, 2025, where standalone and consolidated figures were the same. The company explained that its wholly owned subsidiary, CreditAccess India Foundation, is a Section 8 company undertaking CSR activities and generates no revenue. Subsidiary expenses are funded entirely by the company and recognised as CSR expenditure in the standalone financial statements. Because the subsidiary has no revenue and its expenses are already accounted for as CSR expenses, consolidation has no additional revenue or expense impact, so revenue figures remain the same. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 12 Jan 2026 | results | The Exchange has sought clarification from CREDITACCESS GRAMEEN LIMITED for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the C | |
| 10 Dec 2025 | board outcome Capex, Dividend / buy-back | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Outcome of Board Meeting held on December 10, 2025.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on December 10, 2025, which ran from 10:00 AM to 11:15 AM IST. The board approved issuance of foreign currency bonds and non-convertible debentures, on a private placement basis, in one or more tranches or series, up to an aggregate limit of INR 1,500 crore. The bonds are proposed to be listed on NSE IX or India INX, and the debentures may be listed on BSE or NSE. The tenure, coupon and security terms are to be decided by the Board or its committee from time to time. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Dec 2025 | board outcome Capex, Guidance | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on December 10, 2025.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on December 10, 2025, which ran from 10:00 AM to 11:15 AM (IST). The board approved issuance of foreign currency bonds and non-convertible debentures on a private placement basis, in one or more tranches or series, in domestic or foreign markets. The aggregate issue limit is INR 1,500,00,00,000 (Indian Rupees One Thousand and Five Hundred Crores). The Bonds are proposed to be listed on NSE IX or India INX, and the Debentures may be listed on BSE or NSE. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 02 Nov 2025 | transcript Guidance, Management change, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about TranscriptAI summaryCreditAccess Grameen filed the transcript of its Q2 FY26 earnings call held on October 28, 2025. Management reported Q2 FY26 disbursements of Rs. 5,322 crore (up 32.9% YoY) and PAT of Rs. 126 crore, with ROA of 1.8% and ROE of 7.1%. Management said FY26 credit cost may deviate 70-100 bps above initial guidance, and FY27 credit cost may range 4-4.5% including a one-time ECL rate revision of 70-80 bps. Management said FY27 growth could be 20% plus across retail finance and microfinance, with guidance to be reviewed by year end. Board announcement on the call: Mr. Manoj Kumar appointed as Chairman and Independent Director. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Oct 2025 | board outcome Management change, Results | CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2025.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on October 28, 2025, which approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, with a limited review report from the joint auditors. Mr. Manoj Kumar, Independent Director (DIN: 02924675), was elected Chairman of the Board with immediate effect. Ms. Jessie Paul, Independent Director, was appointed Chairperson of the Nomination & Remuneration Committee in place of Mr. Manoj Kumar with immediate effect. M/s. Sundaram & Srinivasan, Chartered Accountants (FRN: 004207S), was approved, subject to shareholder approval, as one of the Joint Statutory Auditors for a 3-year term from FY 2026-27, replacing M/s Varma & Varma, whose tenure ends at the AGM in 2026. The board meeting commenced at 2:30 PM and concluded at 5:50 PM (IST). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Oct 2025 | presentation Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its investor presentation for Q2 and H1 FY26 (quarter and half year ended September 30, 2025). Q2 FY26 gross loan portfolio (GLP) was INR 25,904 Cr, disbursements INR 5,322 Cr (up 32.9% YoY), and PAT INR 126 Cr. GNPA (GL: 60+ dpd, RF: 90+ dpd) was 3.65%, NNPA 1.26%, and CRAR 26.1% (Tier 1: 25.2%). Credit cost fell sequentially to INR 526 Cr in Q2 FY26 from INR 572 Cr in Q1 FY26, including INR 683 Cr of accelerated write-offs. Management said it sees gradual stabilisation in asset quality, with PAR 15+ accretion range-bound due to heavy rains and floods, and expects strong business momentum to drive robust profitability in H2 FY26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Oct 2025 | board outcome Legal, Management change, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on October 28, 2025.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on October 28, 2025 (meeting ran 2:30 PM to 5:50 PM IST). The board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, along with a limited review report from the auditors. Mr. Manoj Kumar, Independent Director (DIN: 02924675), was elected Chairman of the Board with immediate effect, and Ms. Jessie Paul was appointed Chairperson of the Nomination & Remuneration Committee in his place. The board approved appointing M/s. Sundaram & Srinivasan, Chartered Accountants (FRN: 004207S), as one of the Joint Statutory Auditors for a 3-year term from FY 2026-27, subject to shareholder approval, replacing M/s Varma & Varma when its tenure ends at the AGM in 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 09 Aug 2025 | board outcome Management change | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on August 09, 2025.AI summaryBoard of CreditAccess Grameen Limited, meeting held August 9, 2025 (3:15 PM to 3:50 PM IST), took note of the resignation of M. J. Mahadev Prakash as Company Secretary & Chief Compliance Officer, effective close of business on August 9, 2025 (resignation dated August 7, 2025). The Board approved the appointment of Ms. Deepti Ramani as Company Secretary & Compliance Officer, effective August 10, 2025; she will be a Key Managerial Personnel. Ms. Deepti Ramani has over 11 years of experience in corporate governance, compliance and secretarial functions and joined the company as Assistant General Manager – Compliance & Legal. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jul 2025 | transcript Guidance, Legal, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about TranscriptAI summaryCreditAccess Grameen filed the transcript of its Q1 FY26 results conference call, held on July 22, 2025. Management said Q1 FY26 had the highest-ever first-quarter disbursement, with PAR 15+ new accretion at 0.46% in June 2025 versus 1.34% in November 2024, and Karnataka's PAR 15+ accretion at 0.58% in June 2025 from a 2% peak in February 2025. Management reported PAT of Rs 60 crore for Q1 FY26, ROA of 0.9%, ROE of 3.4%, NII of Rs 937 crore, and a collection efficiency excluding arrears of 93.2%. Management said it wrote off Rs 693 crore in Q1 FY26, including an accelerated write-off of Rs 603 crore, and that it expects robust profitability in the second half of FY26 as guided. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Jul 2025 | presentation Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its Q1 FY26 (quarter ended June 30, 2025) investor presentation, also posted on the company website. Q1 FY26: disbursements INR 5,458 Cr (up 21.9% YoY), GLP INR 26,055 Cr, NII INR 937 Cr, PPOP INR 653 Cr, PAT INR 60 Cr. GNPA 4.70%, PAR 90+ 3.29%, ECL provisioning 4.62%, NNPA 1.78%, CRAR 25.5%. Q1 FY26 included INR 603.2 Cr of accelerated write-offs; management said this is part of balance sheet normalization in H1 FY26, with robust profitability expected in H2 FY26. Management said monthly PAR 15+ accretion fell to 0.46% in Jun-25 from 1.34% in Nov-24, and credit cost fell from INR 752 Cr in Q3 FY25 to INR 572 Cr in Q1 FY26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Jul 2025 | board outcome | CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended Jun 30, 2025. | NSE copy |
| 22 Jul 2025 | board outcome Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on July 22, 2025.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held on July 22, 2025, approving unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. Standalone total income for Q1 FY26 was Rs 1,463.63 crore, against Rs 1,512.58 crore in the quarter ended June 30, 2024. Standalone profit for the period was Rs 60.19 crore, against Rs 397.66 crore in the quarter ended June 30, 2024. Impairment on financial instruments was Rs 571.85 crore for the quarter, against Rs 174.59 crore a year earlier. Basic EPS was Rs 3.77 for the quarter, against Rs 24.95 a year earlier. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 18 Jun 2025 | board outcome Management change | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on Jun 18, 2025.AI summaryBoard meeting outcome dated June 18, 2025, filed by CreditAccess Grameen Limited under Regulation 30 of the Listing Regulations. The Board reconstituted the Stakeholders Relationship Committee, adding Mr. Massimo Vita (Non-Executive Director) as a member with effect from June 26, 2025, in place of Mr. Udaya Kumar Hebbar. Mr. Udaya Kumar Hebbar's term as Managing Director ends at the close of business on June 25, 2025. The Board noted the interim designation of Mr. Ganesh Narayanan as 'CEO & MD (Designate)' with effect from June 26, 2025, pending RBI approval of his appointment as MD & CEO. The meeting began at 11:00 AM and concluded at 12:30 PM (IST). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2025 | transcript Guidance, Management change, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about TranscriptAI summaryCreditAccess Grameen filed the transcript of its Q4 FY25 results conference call, held on May 16, 2025. Management said Q4 FY25 profit was INR 47 crore, FY25 credit cost was INR 1,929 crore (7.7%), and FY25 NIM was 12.9%, with the Karnataka stress cited as the reason results fell short of the revised FY25 growth guidance of 7-8%. Management guided FY26 AUM growth of 14% to 18%, NIM of 12.6% to 12.8%, credit cost of 5.5% to 6%, ROA of 2.9% to 3.4% and ROE of 11.8% to 13.3%. Managing Director Udaya Kumar Hebbar will retire on June 25, 2025 and become a non-executive Nominee Director from June 26, 2025; CEO Ganesh Narayanan is to be appointed Managing Director & CEO for five years from June 26, 2025, subject to RBI and shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 May 2025 | presentation Guidance, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryRevised investor presentation for Q4 and FY25 (quarter and year ended March 31, 2025) filed under Regulation 30 and 46 of SEBI LODR. Q4 FY25: GLP INR 25,948 Cr (down 2.9% YoY, up 4.6% QoQ), disbursements INR 6,472 Cr, PAT INR 47 Cr, GNPA 4.76%, CRAR 25.4%. FY25: NII INR 3,623 Cr, PPOP INR 2,638 Cr, PAT INR 531 Cr, ROA 1.9%, ROE 7.7%. Total write-off of INR 518.2 Cr in Q4, including INR 479.2 Cr accelerated write-off, resulting in additional credit cost of about INR 150.7 Cr. Management said PAR accretion is near-to-normalised in all states excluding Karnataka and expects Karnataka delinquency to normalise by end of Q1 FY26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 May 2025 | board outcome Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.AI summaryCreditAccess Grameen Limited filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, dated May 16, 2025. Standalone total revenue from operations for FY2024-25 was Rs 5,756.14 crore (year ended March 31, 2024: Rs 5,172.65 crore) as printed in the statement. Standalone profit for the year was Rs 504.21 crore versus Rs 1,431.24 crore... no; the printed FY2024-25 standalone profit after tax is Rs 504.21 crore against Rs 1,431.24 crore in FY2023-24 for the comparative year, and Q4 FY2024-25 profit was Rs 47.21 crore. Basic EPS for Q4 FY2024-25 was Rs 2.96 and for the full year Rs 24.93 (standalone, as printed). The company stated that the joint statutory auditors expressed an unmodified opinion on the results. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 May 2025 | presentation Guidance, Legal, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its Q4 and FY25 investor presentation, dated May 16, 2025, under Regulations 30 and 46 of the SEBI LODR. Q4 FY25: NII INR 876 Cr, PPOP INR 634 Cr, PAT INR 47 Cr; FY25: NII INR 3,623 Cr, PPOP INR 2,638 Cr, PAT INR 531 Cr. Q4 FY25 total write-off was INR 518.2 Cr, including INR 479.2 Cr of accelerated write-off, implying additional credit cost of about INR 150.7 Cr. Q4 FY25 GNPA was 4.76%, NNPA 1.73%, and CRAR 25.4% (Tier 1: 24.5%); FY25 ROA was 1.9% and ROE 7.7%. Management said PAR accretion is near-to-normalised in all states except Karnataka, and that the company is well poised for FY26 on stabilising asset quality and improving business momentum. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 May 2025 | board outcome Capex, Legal, Management change, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on May 16, 2025.AI summaryCreditAccess Grameen Limited filed the outcome of its board meeting held May 16, 2025, approving audited standalone and consolidated results for the quarter and year ended March 31, 2025. Standalone Q4 FY25 (quarter ended March 31, 2025) profit after tax was ₹47.21 crore against a loss of ₹199.52 crore... [see note] Standalone profit for FY25 (year ended March 31, 2025) was ₹387.48 crore, versus ₹504.21 crore in the prior year (FY24 column). The board re-appointed Ms. Lilian Jessie Paul as Independent Director for a second 5-year term from September 16, 2025, and appointed Mr. Ganesh Narayanan as Managing Director & CEO for 5 years from June 26, 2025, both subject to RBI and shareholder approval. The board also approved raising up to ₹2,000 crore through a public issue of non-convertible debentures in one or more tranches, and appointed Mr. Udaya Kumar Hebbar as Non-Executive Director (Nominee) from June 26, 2025, subject to RBI and shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Mar 2025 | results Legal | The Exchange had sought clarification from CREDITACCESS GRAMEEN LIMITED for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the CAI summaryCreditAccess Grameen Limited filed a clarification dated March 03, 2025, responding to an NSE email dated February 27, 2025, on its financial results format. The company said standalone and consolidated profit and loss figures are the same because CSR expenses under Section 135 of the Companies Act are accounted for consistently after offsetting the donation from CAGL to its wholly owned subsidiary CreditAccess India Foundation. The company said standalone and consolidated balance sheets differ because consolidation adds the subsidiary's assets and liabilities line by line. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 27 Feb 2025 | results | The Exchange has sought clarification from CREDITACCESS GRAMEEN LIMITED for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the C | |
| 10 Feb 2025 | results Results | Integrated Filing for the quarter ended December 31, 2024AI summaryCreditAccess Grameen filed its integrated filing (financial) for the quarter ended December 31, 2024, including unaudited standalone financial results with an auditor's review report dated January 24, 2025. For Q3 FY25 (quarter ended Dec 31, 2024), total income was Rs 1,381.93 crore and the company reported a loss before tax of Rs 128.93 crore and a net loss of Rs 99.52 crore, against a net profit of Rs 353.42 crore in the year-ago quarter. Impairment on financial instruments was Rs 751.86 crore in the quarter, versus Rs 126.20 crore a year earlier. For the nine months ended Dec 31, 2024, total income was Rs 4,348.43 crore and net profit was Rs 484.19 crore; basic EPS for the nine months was Rs 30.37 (not annualised), and the quarter's basic EPS was Rs (6.24). The filing also includes the statement on deviation/variation of proceeds (not applicable), disclosure of outstanding defaults on loans and debt securities, and related party transactions. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jan 2025 | transcript Guidance, Legal, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about TranscriptAI summaryTranscript filed of CreditAccess Grameen's Q3 FY25 results conference call held on January 24, 2025. Management said PAR 15+ was 6.3% overall, with new delinquency addition expected to normalise by Q4 FY25 or Q1 FY26, and AUM was INR 24,810 Crore as of December 2024 and INR 25,125 Crore as of January 20, 2025. Management reported Q3 FY25 credit cost of INR 750 Crore, including accelerated write-offs of INR 229 Crore adding INR 73 Crore to credit cost, and PAR 90 of 2.64%, GNPA of 3.99% and net NPA of 1.28%. Management guided FY25 AUM growth of 7%-8%, NIM of 12.8%-13.0%, credit cost of 6.7%-6.9%, ROA of 2.3%-2.4% and ROE of 9.5%-10.0%, and a preliminary FY26 outlook of 18%-20% AUM growth, 4.2%-4.5% ROA and 17%-19% ROE. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jan 2025 | presentation Guidance, Legal, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange about Investor PresentationAI summaryCreditAccess Grameen filed its investor presentation for the quarter and nine months ended December 31, 2024 (Q3 & 9M FY25). Q3 FY25 PAT was INR -99.5 Cr and 9M FY25 PAT was INR 484 Cr; Q3 NII was INR 862 Cr and GLP was INR 24,810 Cr (up 6.1% YoY). Q3 included an accelerated write-off of INR 229.4 Cr and total write-offs of INR 376.7 Cr, resulting in an additional credit cost of about INR 73 Cr, per management. Management said PAR accretion has reverted since mid-November 2024 and expects a return to normalised accretion by Q4 FY25 or Q1 FY26. CRAR was 25.9% and GNPA was 3.99% as of December 2024. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jan 2025 | board outcome Capex, Dividend / buy-back, Results | CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Board meeting held on January 24, 2025.AI summaryCreditAccess Grameen Limited's board on January 24, 2025 approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, with a limited review report from the auditors. The board granted 15,57,900 stock options to eligible employees under the CAGL Employees Stock Option Plan – 2011, at an exercise price of ₹955.94; 25% of the options vest in four years from grant. The company launched the digital customer handle MAHI app for end-to-end digital lending and an Affordable Housing Loan product, both on January 24, 2025. Diluted EPS as on December 31, 2024 is stated as Rs. -6.24 in the ESOP disclosure. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.